drugset / Trial / NCT00868998
GTX Regimen for Biliary Cancers
NaSingle-groupOpen-labelTreatment
Summary
This is a study for patients with advanced cancer of the biliary tree, such as cholangiocarcinoma. They will be treated with a chemotherapy regimen consisting of Gemcitabine, Taxotere, and Xeloda every 21 days for at least 9 weeks. Treatment will continue until their cancer progresses. This chemotherapy regimen has been used in pancreatic cancer and there is reason to believe that it will be effective for cancers of the biliary tree as well.
Timeline
- Start
- 2005-08
- Primary completion
- 2010-09
- Completion
- 2010-10
Outcome
Outcome not reported
Stopped (Enrollment): “Poor patient accrual”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capecitabine | Small molecule | 600 mg/m2 | Oral |
| Subject | Docetaxel | Small molecule | 30 mg/m2 | Intravenous |
| Subject | Gemcitabine | Small molecule | 600 mg/m2 | Intravenous |